TriMas Corp
130 hedge funds and large institutions have $1.14B invested in TriMas Corp in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
12% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 42
0.48% less ownership
Funds ownership: 100.65% → 100.17% (-0.48%)
2% less capital invested
Capital invested by funds: $1.16B → $1.14B (-$20.3M)
2% less funds holding
Funds holding: 132 → 130 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Top Buyers
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$8.56M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$4.69M |
| 3 |
Pzena Investment Management
New York
|
-$2.26M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.33M |
| 5 |
First Manhattan
New York
|
-$1.32M |
TRS Hedge Fund Activity: Q2 2023 in Review
130 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TriMas Corp (TRS) for Q2 2023, worth a combined $1.14B — down 1.7% from $1.16B a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TRS and 10 opened new positions — a net loss of 2 holders — while 42 trimmed existing stakes and 47 added.
The largest buyer was Fiduciary Management Inc, adding an estimated $4.24M. The largest seller was Royce & Associates, cutting an estimated $8.56M.
- 130 institutional investors held TriMas Corp (TRS) as of Q2 2023, down from 132 in Q1 2023.
- Funds reported $1.14B of TriMas Corp stock for Q2 2023, down 1.7% quarter-over-quarter.
- 10 funds opened new TriMas Corp positions in Q2 2023 and 12 closed out, a net change of -2 holders.
- The largest TriMas Corp buyer in Q2 2023 was Fiduciary Management Inc, an estimated $4.24M added.
- The largest TriMas Corp seller in Q2 2023 was Royce & Associates, an estimated $8.56M sold.
Based on aggregated 13F filings for Q2 2023.